===============================================================
==                   -- ALS INTEREST GROUP --                ==
== ALS DIGEST (#18, 05 FEB 1993)                             ==
== To subscribe, unsubscribe, or to contribute notes, please ==
== send e-mail to bro@huey.met.fsu.edu (Bob Broedel).        ==
===============================================================

these references are for the article in # 18

E) REFERENCES

Albers, G. W., Goldberg, M. P., Choi, D. W. (1989). N-methyl-D-
aspartate antagonists:  ready for clinical trial in brain ischemia? 
Annals of neurology, 25, 398-403.

Allaoua, H., Chaudieu, I., Krieger, C., Boksa, P., Privat, A., Quirion, R.
(1992). Alterations in spinal cord excitatory amino acid receptors in
amyotrophic lateral sclerosis  patients. Brain research, 579, 169-172.

Andersson, T., Schultzberg, M., Schwarcz, R., L ve, A., Wickman, C. and
Kristens-son, K. (1991). European journal of neuroscience, 3, 66-71.

Aanonsen, L. M., Lei S., Wilcox, G. L. (1990). Excitatory amino acid
receptors and nociceptive neurotransmission in rat spinal cord. Pain, 41,
309-321.

Arslan, M., Pohl, C. R. and Plant, T. M. (1988). 
DL-2-amino-5-phosphonopentanoic acid, a specific N-methyl-D-aspartic 
acid receptor antagonist, suppresses pulsatile LH release in the 
rat. Neuroendocrinology, 47, 465-468.

Bennett, D. A., Lehmann, J., Bernard, P. S., Liebman, J. M., 
Williams, M., Wood, P. L., Boast, C. A., Hutchison, A. J. (1990). 
CGS 19755: a novel competitive N-methyl-D- aspartate (NMDA) 
receptor antagonist with anticonvulstant, anxiolytic and anti-
ischemic properties. Current and future trends in anticonvulsant, 
anxiety, and stroke therapy, 519-524.

Bertrand, G., Gross, R., Puech, R., Loubati res-Mariani, M. M., 
Bockaert, J. (1992). Evidence for a glutamate receptor of the 
AMPA subtype which mediates insulin release from rat perfused 
pancreas. British journal of pharmacology, 106, 354-359.

Bobbin, R. P. and Ceasar, G. (1987). Kynurenic acid and  
-D-glutamylamino-methylsulfonic acid suppress the compound 
action potential of the auditory nerve. Hearing research, 25, 
77-81.

Bullock, R. Graham, D. I., Chen, M.-H., Lowe, D., McCulloch, J. 
(1990). Focal cerebral ischemia in the cat: pretreatment with 
a competitive NMDA receptor antagonist, D- CPP-ene. Journal of 
cerebral blood flow nd metabolism, 10, 668-674.

Brann, D. W., Mahesh, V. B. (1991). Endogenous excitatory amino 
acid regulation of the progesterone-induced LH and FSH surge 
in estrogen-primed ovariectomized rats.  Neuroendocrinology, 
53, 107-110.

Carlsson, M., Carlsson, A. (1990). Interactions between 
glutamatergic and monoami-nergic systems within the basal 
ganglia - implications for schizophrenia and Parkinson's  
disease. Trends in neurosciences, 13, 272-276.

Cherubini, E., Herrling, P. L., Lanfumey, L. and 
Stanzione, P. (1988). Excitatory amino acids in synaptic 
excitation of rat striatal neurones in vitro. Journal of
physiology, 400, 677-690.

Choi, D. W. (1990). The role of glutamate neurotoxicity in 
hypoxic-ischemic neuronal death. Annual revue of neuroscience, 
13, 171-182.

Davies, J., Evans, R. H., Herrling, P. L., Jones, A. W., 
Olverman, H. J., Pook, P. and Watkins, J. C. (1986). CPP, a 
new potent and selective NMDA antagonist. Depression of central 
neuron responses, affinity for [3H]D-AP5 binding sites on brain
membranes and anticonvulsant activity. Brain research, 382, 169-173.

Davies, J. (1988). A reappraisal of the role of NMDA and non-NMDA 
receptors in neurotransmission in the cat dorsal horn. In Frontiers 
in excitatory amino acid research (eds. E. Cavalheiro, J. Lehmann, L. 
Turski) A.R.Liss, New York, pp. 355-362.

Davies, S. N. and Lodge, D. (1987). Evidence for involvement of
N-methylaspartate receptors in 'wind-up' of class 2 neurones in 
the dorsal horn of the rat. Brain research, 424, 402-406.

Delay, J., Deniker, P. and Havl, J. M. (1952). Utilisation th 
rapeutique psychiatrique d'une ph nothiazine d'action centrale s 
lective. Annales m dicales psychologiques, 110,  112-117.

Duncan, M. W., Marini A. M., Watters, R., Kopin I. J, 
Markey, S. P. (1992). Zinc, a  neurotoxin to cultured neurons, 
contaminates cycad flour prepared by traditional guamanian 
methods. The journal of neuroscience, 1523-1537.

Dunn, R. W., Corbett, R., Martin, L. L., Payack, J. F., 
Laws-Ricker, R., Wilmot, C. A.,  Rush, D. K., Cornfeldt, M. L., 
Fielding, S. (1990). Preclinical anxiolytic profiles of 7189  
and 8319, novel non-competitive NMDA antagonists. Current and 
future trends in  anticonvulsant, anxiety, and stroke therapy, 
495-512.

Eaton, S. A. and Salt, T. E. (1987). N-Methyl-D-aspartate 
antagonists reduce the responses of rat thalamic neurones to 
noxious stimulation. Journal of physiology, (London), 394, 114P.

Ehrenberger, K. and Brix, R. (1983). Glutamic acid and glutamic 
acid diethylester in tinnitus treatment. Acta otolaryngol, 
95, 599-605.

Emmett, M. R., Mick, S. J., Cler, J. A., Rao, T. S., 
Iyengar, S., Wood, P. L. (1991). Actions of D-cycloserine at 
the N-methyl-D-aspartate-associated glycine receptor site
in vivo. Neuropharmacology, 30, 1167-1171.

Erdoe, S. L. (1991). Excitatory amino acid receptors in the mammalian
periphery. Trends in pharmacological sciences, 12, 426-429.

Estienne, M. J., Schillo, K.K., Hileman, S. M., Green, M. A., 
Hayes, S. H. (1990a). Effect  of N-methyl-D,L-aspartate on 
luteinizing hormone secretion in ovariectomized ewes in the 
absence and presence of estradiol. Biology of reproduction, 42,
126-130.

Estienne, M. J., Schillo, K. K., Green, M. A., Hileman, S. M. 
(1990b). Growth hormone release after N-methyl-D,L-aspartate in 
sheep: dose response and effect of an opioid  antagonist. Journal 
of animal sciences, 68, 3198-3203.

Faden, A. I., Ellison, J. A., Noble, L. J. (1990). Effects of 
competitive and non-competitive NMDA receptor antagonists in 
spinal cord injury. European journal of pharmacology, 175, 
165-174.

Farah, J. M., Rao, T. S., Mick, S. J., Coyne, K. E., 
Iyengar, S. (1991). N-methyl-D-aspartate treatment increases 
circulating adrenocorticotropin and luteinizing hormone
in the rat. Endocrinology, 128, 1875-1880.

Ferrari, M. D., Odink, J., Bos, K. D., Malessy, M. J. A., 
Bruyn, G. W. (1990). Neuroexcitatory plasma amino acids are 
elevated in migraine. Neurology, 40, 1582-1586.

France, C. P., Wood, J. H. and Ornstein, P. (1989). The 
competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 
attenuates the rate-decreasing effects of NMDA in rhesus monkeys 
without producing ketamine-like discriminative stimulus effects. 
European journal of pharmacology, 159, 133-139.

Freed, W.J. (1988). The therapeutic latency of neuroleptic 
drugs and nonspecific postjunctional supersensitivity. 
Schizophrenia bulletin, 14, 269-277.

Freese, A., Swartz, K. J., During, M. J., Martin, J. B. 
(1990). Kynurenine metabolites of  trypthophan: implications 
for neurologic diseases. Neurology, 40, 691-695.

Fuxe, K., Roberts, P. and Schwarcz, R. (1983). Excitotoxins. 
MacMillan Press, London.

Glavin,G.B., Pinsky,C. and Bose,R. (1989). Mussel poisoning 
and excitatory amino acid  receptors. Trends in pharmaceutical 
sciences, 10, 15-16.

Glavin, G. B., Pinsky, C., Bose, R. (1990). Domoic acid-induced 
neurovisceral toxic syndrome: characterization of an animal model 
and putative antidotes. Brain research bulletin, 24, 701-703.

Gotti. B., Duverger, D., Bertin, J., Carter, C., Dupont, R., 
Frost, J., Gaudilliere, B., MacKenzie, E., Rousseau, J., 
Scatton, B. and Wick, A. (1988). Ifendopril and SL 82.0715 as 
cerebral anti-ischemic agents. I. Evidence for efficacy in 
models of focal cerebral ischemia. Journal of pharmaceutical 
experimental therapeutics, 247, 1211-1221.

Greenamyre, J. T. (1986). The role of glutamate in 
neurotransmission and in neurologic disease. Archives of 
neurology, 43, 1058-1063.

Greenamyre, J. T. and O'Brien, C. F. (1991). 
N-methyl-D-aspartate antagonists in the treatment of Parkinson's 
disease. Archives of neurology, 48, 977-981.

Gribkoff, V. K. and Dudek, F. E. (1988). The effects of the 
excitatory amino acid antagonist kynurenic acid on synaptic 
transmission to supraoptic neuroendocrine cells.
Brain research, 442, 152-156.

Giulian, D., Vaca K., Noonan, C. A. (1990). Secretion of 
neurotoxins by mononuclear phagocytes infected with HIV-1. 
Science, 250, 1593-1596.

Haley, J. E., Sullivan, A. F., Dickenson, A. H. (1990). 
Evidence for spinal N-methyl-D- aspartate receptor involvement 
in prolonged chemical nociception in the rat. Brain research, 
518, 218-226.

Hansen, A. J., Lauritzen, M. and Wieloch, T. (1988). 
NMDA antagonists inhibit cortical  spreading depression, but not 
anoxic depolarization. In Frontiers in excitatory amino  acid 
research (eds. E. A. Cavalheiro, J. Lehmann, L. Turski) A. R. Liss,
New York, pp.  661-666

Harrison, P. J., McLaughlin, D., Kerwin, R. W. (1991). Decreased 
hippocampal expression of a glutamate receptor gene in 
schizophrenia. Lancet, 337, 450-452.

Hayashi, T.A. (1954). Effects of sodium glutamate on the 
nervous system. Keio journal  of medicine 3, 183-192.

Henderson, G., Johnson, J. W., Ascher, P. (1990). Competitive 
antagonists and partial agonists at the glycine modulatory site 
of the mouse N-methyl-D-aspartate receptor.
Journal of physiology, 430, 189-212.

Herberg, L. J., Rose, J. C. (1990). Effects of D-cycloserine and 
cycloleucine, ligands for  the NMDA-associated strychnine-
insensitive glycine site, on brain-stimulation reward and 
spontaneous locomotion. Pharmacology, biochemistry and behavior, 
36, 735-738.

Herrling, P. L. (1985). Pharmacology of the corticocaudate 
excitatory postsynaptic potential in the cat: evidence for its 
mediation by quisqualate- or kainate-receptors.
Neuroscience, 14, 417-426.

Herrling, P. L. and Hull, C. D. (1980). Iontophoretically 
applied dopamine depolarizes and hyperpolarizes the membrane of 
cat caudate neurons. Brain research, 192, 441-462.

Herrling, P. L., Morris, R. and Salt, T. E. (1983). Effects of 
excitatory amino acids and their antagonists on membrane and 
action potentials of cat caudate neurones.
Journal  of physiology, 339, 207-222.

Heyes, M. P., Brew, B. J., Martin, A., Price, R. W., 
Salazar, A. M., Sidtis, J. J., Yergey, J.  J., Mouradian, M. M.,
Sadler, A. E., Keilp, J., Rubinow, D., and Markey, S. P. (1991). 
Quinolinic acid in cerebrospinal fluid and serum in HIV-1
infection: relastionship to clinical and neurological status.  
Annals of neurology, 29, 202-209.

Honor , T. (1989). Excitatory amino acid receptor subtypes 
and specific antagonists. Medicinal research reviews, 9, 1-23.

Hood, W. F., Compton, R. P., Monahan, J. B. (1989). 
D-Cycloserine: a ligand for the N- methyl-D-aspartate coupled 
glycine receptor has partial agonist characteristics.
Neuroscience letters, 98, 91-95.

Imperato, A., Scrocco,M. G., Bacchi, S., and Angelucci, L. 
(1990). NMDA receptors and in vivo dopamine release in the 
nucleus accumbens and caudatus. European journal of pharmacology, 
187, 555-556.

Jensen, L. H. and Sheardown, M. (1988). Lack of potent 
antiepileptic effect of specific non-NMDA EAA receptor 
antagonist. In Frontiers in excitatory amino acid research  
(eds. E. A. Cavalheiro, J. Lehmann and L. Turski) A. R. Liss, 
New York, pp.  219-226.

Johnson, J., Ascher, P. (1987). Glycine potentiates the NMDA 
response in cultured mouse brain neurons. Nature, 325, 529-531.

Katayama, Y., Becker, D. P., Tamura, T., Hovda, D. A. (1990). 
Massive increase in extracellular potassium and the indiscriminate 
release of glutamate following concussive brain injury. Journal 
of Neurosurgery, 73, 889-900.

Kehne, J. H., McCloskey, T. C., Baron, B. M., Chi, E. M., 
Harrison, B. L., Whitten, J. P.,  Palfreyman, M. G. (1991): 
NMDA receptor complex antagonists have potential anxiolytic 
effects as measured with separation-induced ultrasonic 
vocalizations. European journal of pharmacology, 193, 283-292.

Kemp, J. A. and Sillito, A. M. (1983). The nature of the 
excitatory transmitter mediating  X and Y cells inputs to 
the cat dorsal lateral geniculate nucleus. Journal of physiology, 
323, 377-391.

Khanna, J. M., Wu, P. H., Weiner, J., Kalant, H. (1991). 
NMDA antagonists inhibits rapid tolerance to ethanol. 
Brain research bulletin, 26, 643-645.

Kjellmer, I. (1991). Mechanisms of perinatal brain damage. 
Annals of medicine, 23, 675- 679.

Klepstad, P., Maurset, A., Moberg, E. R., Oye, I. (1990). 
Evidence of a role for NMDA  receptors in pain perception. 
European journal of pharmacology, 187, 513-518.

Kleinschmidt,A., Bear,M.F. and Singer,W. (1987). Blockade of 
"NMDA" receptors disrupts experience-dependent plasticity of 
kitten striate cortex. Science, 238, 355-358.

Klockgether, T., Turski, L. (1990). NMDA antagonists potentiate 
antiparkinsonian actions of L-Dopa in monoamine-depleted rats. 
Annals of neurology, 25, 539-546.

Koh, J., Yang, L. L., Cotman, C. W. (1990).  -Amyloid protein 
increases the vulnerability of cultured cortical neurons to 
excitotoxic damage. Brain research, 533, 315-320.

Laborit, H., Huguenard, P., and Alluaume, R. (1952). Un nouveau 
stabilisateur v g tatif  (le 4560 RP). La presse m dicale, 60, 
206-208.

Lauritzen, M. (1988). Cortical spreading depression: a putative 
migraine mechanism. Trends in neurosciences, 10, 8-12.

Liebman, J. M. and Bennett, D. A. (1988). Anxiolytic actions 
of competitive N-methyl-D-aspartate receptor antagonists: a 
comparison with benzodiazepine modulators and dissociative 
anesthetics. In Frontiers in excitatory amino acid research
(eds. E. A. Cavalheiro, J. Lehmann and L. Turski) A. R. Liss, 
New York, pp. 301-308.

Liljequist, S. (1991). The competitive NMDA receptor antagonist, 
CGP 39551, inhibits  ethanol withdrawal seizures. European Journal 
of Pharmacology, 192, 197-198.

Liu, D., Thangnipon, W., McAdoo, D. J. (1991). Excitatory amino 
acids rise to toxic levels upon impact injury to the rat spinal 
cord. Brain research, 547, 344-348.

Lodge, D., Aram, J. A., Church, J., Davies, S. N., Martin, D., 
Millar, J. and Zeman, S. (1988). Sigma opiates and excitatory 
amino acids. In Excitatory amino acids in health and disease 
(ed. D. Lodge) J. Wiley and  Sons, New York, pp. 237-259.

Lopez, F.J., Donoso, A. O., Negro-Vilar, A. (1990). Endogenous 
excitatory amino acid neurotransmission regulates the estradiol-
induced LH surge in ovarieectomized rats.  Endocrinology, 126, 
1771-1773.

Lucas, D. R. and Newhouse, J. P. (1957). The toxic effect of 
sodium-L-glutamate on the inner layers of the retina. Archives 
of ophtalmology 58, 193-204.

Man, E. H., Sandhouse, M. E., Burg J. and Fisher G.H. (1983). 
Accumulation of D-aspartic acid with age in the human brain. 
Science, 220, 1407-1408.

Mansbach, R. S. (1991). Effects of NMDA receptor ligands on 
sensorimotor gating in the rat. European journal of pharmacology, 
202, 61-66.

Maragos, W. F., Greenamyre, J. T., Penney, J. B. and Young, A. B. 
(1987). Glutamate dysfunction in Alzheimer's disease: an hypothesis. 
Trends in neurosciences, 65-68.

Marranes, R., Willems, R., De Prins, E. and Wauquier, A. (1988). 
Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor 
in cortical spreading depression in the rat. Brain research 457, 
226-240.

Mason, G. A., Bissette, G. and Nemeroff, C. B. (1983). Effects of 
excitotoxic amino acids on pituitary hormone secretion in the rat. 
Brain research, 289, 366-369.

Meldrum, B., Wardley-Smit, B., Halsey, M. and Rostain, J.C. (1983). 
2-Amino-phosphonoheptanoic acid protects against the high pressure 
neurological syndrome. European journal of pharmacology, 87, 501-502.

Meldrum, B. (1985). Possible therapeutic applications of 
antagonists of excitatory amino  acid neurotransmitters. 
Clinical science, 68, 113-122.

Meldrum, B. (1986). Drugs acting on amino acid neurotransmitters. 
Advances in neurology, 43, 687-706.

Meldrum, B. S. and Kerwin, R. W. (1987). Glutamate receptors and 
schizophrenia. Journal of psychopharmacology 1, 217-221.

Meldrum, B.S. (1988). What are the future prospects for agents 
decreasing excitatory neurotransmission as anti-epileptic agents? 
In Frontiers in excitatory acid research (eds.  E. A. Calvalheiro, 
J. Lehmann and L. Turski) A. R. Liss, New York, pp. 195-202.

Miller, R. F. and Slaughter, M. M. (1986). Excitatory amino 
acid receptors of the retina:  diversity of subtypes and 
conductance mechanisms. Trends in neurosciences, 9, 211- 218.

Monahan, J. B., Handelmann, G. E., Hood, W. F., Cordi, A. A. 
D-cycloserine, a positive  modulator of the N-methyl-D-aspartate 
receptor, enhances performance of learning  tasks in rats. 
Pharmacology biochemistry and behavior, 34, 649-653.

Mondadori, C., Ortmann, R., Petschke, F., Buerki, H., 
D'Amato, F., Meisburger, J. G. Fagg, G. E. (1988). In Frontiers 
in excitatory acid research (eds. E. A. Cavalheiro,
J. Lehmann and L. Turski ) A. R. Liss, New York, pp. 419-426.

Moroni, F., Lombardi, G., Carla, V., Pellegrini, D., 
Carassale, G. L. and Cortesini, C. (1986). Content of quinolinic 
acid and of other tryptophan metabolites increases in brain 
region of rats used as experimental models of hepatic 
encephalopathy. Journal of neurochemistry, 46, 869-874.

Moroni,F., Luzzi,S., Franchi-Micheli,S., Zilletti,L. (1986). 
The presence of NMDA-type receptors for glutamic acid in the 
guinea pig myenteric plexus. Neuroscience letters,  68, 57-62.

Morris, R. G. M., Anderson, E., Lynch, G. S. and Baudry, M. 
(1986). Selective impairment of learning and blockade of 
long-term potentiation by an N-methyl-D-aspartate  receptor 
antagonist, AP5. Nature, 319, 774-776.

ye, V., Paulsen, O. and Maurset, A. (1992). Effects of ketamine 
on sensory perception:  evidence for a role of N-methyl-D-aspartate 
receptors. The journal of pharmacology and experimental therapeutics, 
260, 1209-1213.

Ozyurt, E., Graham, D. I., Woodruff, G. N. and McCulloch, J. 
(1988). Protective Effect  of the Glutamate Antagonist, MK-801 
in Focal Cerebral Ischemia in the Cat. Journal of cerebral blood 
flow and metabolism, 8, 138-143.

Palmer, A. M., Gershon, S. (1990). Is the neuronal basis of 
Alzheimer's disease cholinergic or glutamatergic? FASEB journal, 
4, 2745-2752.

Parada-Turska, J., Turski, W. A. (1990). Excitatory amino acid 
antagonists and memory:  effect of drugs acting at 
N-methyl-D-aspartate receptors in learning and memory tasks.  
Neuropharmacology, 29, 1111-1116.

Perry, T. L., Krieger, C., Hansen, S., Eisen, A. (1990). 
Amyotrophic lateral sclerosis: amino acid levels in plasma and 
cerebrospinal fluid. Annals of neurology, 28, 12-17.

Plaitakis, A. (1990). Glutamate dysfunction and selective 
motor neuron degeneration in amyotrophic lateral sclerosis: a 
hypothesis. Annals of neurology, 28, 3-8.

Rothman, S. M. (1984). Synaptic release of excitatory amino 
acid neurotransmitter mediates anoxic neuronal death. The 
journal of neuroscience 4, 1884-1891.

Rothman, S. M. and Olney, J. W. (1987). Excitotoxicity and 
the NMDA receptor. Trends in neurosciences, 10, 299-301.

Rothstein , J. D., Tsai, G., Kuncl, R. W., Clawson, L., 
Cornblath, D. R., Drachman, D.  B., Pestronk, A., Stauch, B. L., 
Coyle, J. T. (1990). Abnormal excitatory amino acid metabolism 
in amyotrophic lateral sclerosis. Annals of neurology, 28, 18-
25.

Rothstein, J. D., Martin, L. J., and Kuncl, R. W. (1992). 
Decreased glutamate transport  by the brain and spinal cord in 
amyotrophic lateral sclerosis. The new England journal of 
medicine, 326, 1464-1468.

Salt, T. E. (1987). Excitatory amino acid receptors and 
synaptic transmission in the rat ventrobasal thalamus. 
Journal of physiology, 391, 499-510.

Salt, T. E., Eaton, S. A. (1990). Postsynaptic potentials 
evoked in ventrobasal thalamus neurones by natural sensory 
stimuli. Neuroscience letters, 114, 295-299.

Salt, T. E. (1992). The possible involvement of excitatory 
amino acids and NMDA receptors in thalamic pain mechanisms 
and central pain syndromes. APS journal, 1, 52- 54.

Schwarcz, R., Speciale, C., Gramsbergen, J. B. P. and 
Turski, W. (1988a). Kynurenines in  the mammalian brain. In 
Frontiers in excitatory amino acid research (eds. E. A.  
Cavalheiro, J. Lehmann and L. Turski) A. R. Liss, New York, 
pp. 613-620.

Schwarcz, R., Whetsell, W. O. and Mangano, R. M. (1983). 
Quinolinic acid: an endogenous metabolite that produces 
axon-sparing lesions in rat brain. Science, 219, 316-318.

Schwarcz, R., Whetsell, W. O., Turski, W. A. (1988b). 
Kynurenines and nerve cell death.  Neurodegenerative 
disorders, 7-19.

Serrano, A., D'Angio, M., Scatton, B. (1989). NMDA 
antagonists block restraint-induced increase in 
extracellular DOPAC in rat nucleus accumbens. European
journal of pharmacology, 162, 157-166.

Simon, R. P., Swan, J. H., Griffith, T. and Meldrum, B. S. 
(1984). Blockade of N-methyl- D-aspartate receptors may 
protect against ischemic damage in the brain. Science, 226,  
850-852.

Sherman, A. D., Hegwood, T. S., Baruah, S., Waziri, R. 
(1991). Deficient NMDA-mediated glutamate release from 
synaptosomes of schizophrenics. Biological psychiatry, 30, 
1191-1198.

Spencer, P. S., Hugon, J., Ludolph, A., Nunn, P. B, Ross, S. M., 
Roy, D. N. and Schaumburg H.H. (1987a). Discovery and partial 
characterization of primate motor-system  toxins. In Ciba 
Foundation Symposium 126: Selective Neuronal Death, Wiley
and  Sons, New York. pp. 221-238.

Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., 
Ross, S. M., Roy, D. N. and Robertson,R.C. (1987b). Guam 
amyotrophic lateral sclerosis-parkinsonism-dementia linked 
to a plant excitant neurotoxin. Science, 237, 517-522.

Stephens, D. N. and Andrews, J. S. (1988). N-methyl-D-aspartate 
antagonists in animal  models of anxiety. In Frontiers in 
excitatory amino acid research (eds. E. A. Cavalheiro, J. Lehmann, 
and L. Turski) A. R. Liss, New York, pp. 309-316.

Stone, T. W., Connick, J. H., Winn, P., Hastings, M. H. and 
English, M. (1987). Endoge nous excitotoxic agents. In Ciba 
Foundation Symposium 126: Selective Neuronal Death,  Wiley and 
Sons, New York. pp. 204-220.

Svensson, A., Pileblad, E., Carlsson, M. (1991). A comparison 
between the non-competitive NMDA antagonist dizocilpine (MK-801) 
and the competitive NMDA antagonist  D-CPP-ene with regard to 
dopamine turnover and locomotor-stimulatory properties in  mice. 
Journal of neural transmission [Gensect] 85, 117-129.

Tang, A. H. and Ho, P. M. (1988). Both competitive and non-
competitive antagonists of N-methyl-D-aspartic acid disrupt 
brightness discrimination in rats. European journal of  
pharmacology, 151, 143-146.

The Scientist (1989). February 20, 14.

Thomson, A.M. (1990). Glycine is a coagonist at the NMDA 
receptor/channel complex. Progress in Neurobiology, 35, 53-74.

Thompson, L. T., Moskai, J. R., Disterhoft, J. F. (1992). 
Hippocampus-dependent learning facilitated by a monoclonal 
antibody or D-cycloserine. Nature, 359, 638-641.

Troupin, A. S., Mendius, J. R., Cheng, F. and Risinger, M. W. 
(1986). MK-801. In New  anticonvulsant drugs (eds. B. S. Meldrum 
and R. J. Porter) J. Libbey, London, pp.  191- 201.

Trujillo, K. A., Akil, H. (1991). Inhibition of morphine 
tolerance and dependence by the NMDA receptor antagonist MK-801. 
Science, 251, 85-87.

Trullas, R., Jackson, B., Skolnick, P. (1989). Anxiolytic 
properties of 1-aminocyclo-propane-carboxylic acid, a ligand at 
strychnine-insensitive glycine receptors. Pharmacology  
biochemistry and behavior, 34, 313-316.

Turski, L., Klockgether, T., Sontag, KH, Herrling, P. L. and 
Watkins, J. C. (1987). Muscle relaxant and anticonvulsant activity 
of 3-(+-)-2-carboxy-piperazine-4-yl)propyl- l-phosphonic acid, a 
novel N-methyl-D-aspartate antagonist, in rodent. Neuroscience  
letters, 73, 143-148.

Turski, L., Klockgether, T., Turski, W. A., Ikonomidou, C., 
Schwarz, M. and Sontag, K.  H. (1988). Muscle relaxant action of 
excitatory amino acid antagonists: sites of action.  In Frontiers 
in excitatory amino acid research (eds. E. A. Cavalheiro, J.
Lehmann,  L.  Turski) A. R. Liss, New York, pp. 343-350.

Turski, L., Bressler, K., Rettig, K.-J., Loeschmann, P.-A., 
Wachtel, H. (1991). Protection  of substantia nigra from MPP+ 
neurotoxicity by N-methyl-D-aspartate antagonists.  Nature, 
349, 414-418.

Turski, L., Stephens, D. N. (1992). Excitatory amino acid 
antagonists protect mice against MPP+ seizures. Synapse 10, 
120-125.

Urbanski, H. F., Ojeda, S. R. (1990). A role for N-methyl-D-
aspartate (NMDA) receptors in the control of LH secretion and 
initiation of female puberty. Endocrinology,  126, 1774-1776.

Valverius, P., Crabbe, J. C., Hoffmann, P. L., Tabakoff, B. 
(1990). NMDA receptors in  mice bred to be prone or resistant 
to ethanol withdrawal seizures. European journal of pharmacology, 
184, 185-189.

Van den Pol, A. N., Wuarin, J.-P., Dudek, F. E. (1990). Glutamate, 
the dominant excitatory transmitter in neuroendocrine regulation. 
Science, 250, 1276-1278.

Watkins, J. C. (1988). Thirty years of excitatory amino acid 
research. In Frontiers in excitatory amino acid research (eds. 
E. A. Cavalheiro, J. Lehmann and L. Turski). pp. 3-10.

Whetsell, W. O., Koehler, C. and Schwarcz, R. (1988). Quinolinic 
acid: a glia-derived exitotoxin in the mammalian central nervous 
system. In the Biochemical pathology of astrocytes A.R. Liss, 
New York, pp.191-202.

Wiley, J. W., Lu, Y., Owyang, C. (1991). Evidence for a 
glutamatergic neural pathway in  the myenteric plexus. American 
journal of physiology and gastroenterology, 261, G693- G700.

Woodruff, G. N., Foster, A. C., Wong, E. H .F., Gill, R., 
Kemp, J. A. and Iversen, L. L.  (1988). Excitatory amino acids 
and neurodegenerative disorders: possible therapeutic indications. 
In Excitatory amino acids in health an disease (ed. D. Lodge)
J. Wiley and  Sons, pp. 379-389.

Young, R. S. K., Petroff, O. A. C., Novotny, E. J., Wong, M. 
(1990). Neonatal excitotoxic  brain research. Development 
Neuroscience, 12, 210-220.

== end of als 18-B ==